TX Group AG (SWX:TXGN)

Regulus Therapeutics Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,342	1,925	1,280	1,568	1,657	750
Market Cap Growth	50.37%	50.37%	-18.33%	-5.38%	121.01%	-24.32%
Enterprise Value	2,430	2,168	1,524	1,627	1,741	926
Last Close Price	221.00	176.84	112.70	132.38	133.22	60.31
PE Ratio	-	-	52.48	-	2.07	-
Forward PE	-	18.32	14.15	191.59	48.65	-
PS Ratio	2.49	2.05	1.30	1.70	1.73	0.80
PB Ratio	0.89	0.73	0.50	0.60	0.56	0.38
P/TBV Ratio	1.83	1.51	1.11	1.28	1.09	6.23
P/FCF Ratio	9.40	7.73	7.27	17.92	11.53	6.86
P/OCF Ratio	8.78	7.22	6.47	14.24	10.32	5.85
PEG Ratio	-	1.16	1.16	1.16	1.16	1.16
EV/Sales Ratio	2.58	2.30	1.55	1.76	1.82	0.99
EV/EBITDA Ratio	15.52	30.41	12.35	16.79	13.41	9.87
EV/EBIT Ratio	119.69	-	32.03	64.55	37.69	185.44
EV/FCF Ratio	9.75	8.71	8.65	18.59	12.12	8.46
Debt / Equity Ratio	0.09	0.09	0.10	0.07	0.05	0.05
Debt / EBITDA Ratio	1.85	1.85	1.49	1.36	0.91	0.86
Debt / FCF Ratio	0.98	0.98	1.50	2.01	0.93	0.85
Asset Turnover	0.27	0.27	0.29	0.26	0.29	0.33
Inventory Turnover	101.20	101.20	82.23	101.54	134.13	103.78
Quick Ratio	1.37	1.37	1.20	1.54	1.80	1.25
Current Ratio	1.40	1.40	1.22	1.56	1.81	1.26
Return on Equity (ROE)	1.20%	1.20%	2.31%	-0.14%	33.47%	-4.54%
Return on Assets (ROA)	-0.08%	-0.08%	0.88%	0.44%	0.89%	0.11%
Return on Capital (ROIC)	-0.10%	-0.10%	1.05%	0.53%	1.11%	0.14%
Return on Capital Employed (ROCE)	-	-	1.60%	0.90%	1.40%	0.20%
Earnings Yield	-0.14%	-0.17%	1.91%	-2.81%	48.40%	-14.98%
FCF Yield	10.64%	12.94%	13.76%	5.58%	8.67%	14.58%
Dividend Yield	2.17%	2.71%	1.77%	0.23%	2.40%	-
Payout Ratio	-	-	195.49%	-	-	-
Buyback Yield / Dilution	0.06%	0.06%	-0.05%	0.04%	-0.13%	0.31%
Total Shareholder Return	2.23%	2.77%	1.73%	0.27%	2.27%	0.31%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.